Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

EMD Serono, CVS Health To Partner On TrumpRx Fertility Program Launching In 2026

IVF

On Thursday, President Donald Trump announced the third agreement with a pharmaceutical manufacturer to bring American drug prices in line with the lowest paid by other developed nations, known as the most-favored-nation, or MFN price.

The agreement is with EMD Serono, a unit of Merck KGaA (OTC:MKGAF) (OTC:MKKGY), for its fertility treatments, resulting in substantial cost savings on fertility treatments, including:

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.